Rating History for Summit Therapeutics plc (SMMT) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/17/2025 | Etzer Darout | Upgrade | Equalweight (Underweight) |
18.00 (16.00) |
17.38 (15.11) |
-13.06% | Details |
 |
|||||||
|
|||||||
